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http://dx.doi.org/10.1016/j.asjsur.20Summary A 44-year-old woman was referred to our hospital with pathological nipple
discharge from her left breast. Ultrasonography revealed a solid tumor beneath her left areola
that measured 17 mm in diameter with a dilated mammary duct. Contrast-enhanced magnetic
resonance imaging showed an early-enhanced cystic tumor and a dilated mammary duct. We
performed a duct-lobular segmentectomy using near-infrared indocyanine green (ICG)-fluores-
cence imaging. Under general anesthesia, a silicone tube was inserted into an orifice of a fluid-
discharging mammary duct, and 1 mL dye-fluorescence liquid containing ICG and indigo
carmine was injected into the mammary duct. A periareolar incision was made, and the fluo-
rescence image of the demarcated mammary duct segment was obtained. The mammary duct
segment was dissected, along with the demarcation line. The cystic lesion and dilated
mammary duct were fully resected, and the pathological diagnosis was intraductal papilloma
of the breast. We report that near-infrared ICG fluorescence could be applied for imaging of
the mammary duct segment, and the fluorescence image allowed for easier duct-lobular
segmentectomy for nipple discharge.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Surgery, Nagasaki Municipal Hospital, 6-39 Shinchi-machi, Nagasaki 850-8555, Japan.
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Duct-lobular segmentectomy using ICG-fluorescence 1711. Introduction
As a new technology that can be used for sentinel lymph
node biopsy for breast cancer, near-infrared fluorescence
imaging and lymph node mapping using indocyanine green
(ICG) have been reported to be feasible and safe under
real-time observation of the signals in the subcutis and
lymph nodes.1,2 In addition to breast surgery, the near-
infrared ICG-fluorescence imaging technique has also
been used as a method providing direct intraluminal
enhancement in the bile duct for cholecystectomy.3 We
report that near-infrared ICG-fluorescence could be
successfully applied for imaging of the mammary duct by
direct intraluminal injection into the mammary duct, and
that it made it possible to identify the resection line of the
dilated duct-lobular segment in the mammary parenchyma.
This allows for easier duct-lobular segmentectomy for
patients with pathological nipple discharge.2. Case report
A 44-year-old woman was referred to our hospital with
nipple discharge from her left breast. Mammography
showed the mass shadow and dilated mammary duct.
Ultrasonography revealed a solid tumor beneath the left
areola that was 17 mm in diameter, with a dilated
mammary duct (Fig.1). Contrast-enhanced magnetic
resonance imaging (MRI) showed an early-enhanced and
wash-out pattern of the tumor, in addition to the dilated
mammary duct. Fine needle aspiration cytology was
performed; the findings of which were insufficient to
exclude malignancies of the breast. We planned to
perform a duct-lobular segment ectomy using near-
infrared ICG-fluorescence imaging intraoperatively.
Under general anesthesia, a silicone tube intended for
the treatment of lacrimal passage obstruction (N-S tube;
Kaneka Medicus, Osaka, Japan) was inserted into an
orifice of a fluid-discharging mammary duct, and 1 mL
dye-fluorescence liquid comprising 0.025 mg/mLICG
(Diagnogreen; Daiichi Pharmaceutical, Tokyo Japan) withFigure 1 Ultrasonography revealed a solid tumor beneath
the left areola with a dilated mammary duct.0.02 mg/mL indigocarmine (Daiichi Pharmaceutical) was
injected into the mammary duct.
A periareolar incision was made, the subcutaneous
tissue was dissected, and the fluorescence image of the
demarcated mammary duct segment was obtained thor-
ough a near-infrared fluorescence camera (Photodymanic
Eye; Hamamatsu Photonics, Hamamatsu Japan). Along with
the demarcation line, the mammary duct segment was
dissected (Figs. 2 & 3). The mammary collecting duct just
beneath the nipple was also strongly fluorescent compared
to the subareolar tissue, so the duct was also dissected
from the orifice on the nipple side. The dissected collecting
duct and fluorescence-enhanced mammary duct segment of
the parenchyma were removed en bloc toward the
peripheral mammary parenchyma, as guided by the fluo-
rescence. During the resection, the cystic lesion and
dilated mammary duct were fully removed, and the path-
ological diagnosis was concluded to be intraductal papil-
loma of the breast (Figs. 4 & 5).
3. Discussion
Nipple discharge is the third most common breast
complaint, after breast pain and breast lumps, with a re-
ported prevalence of approximately 5%.4 Nipple discharge
can be divided into three categories: physiological, para-
physiological, and pathological. Pathological nipple
discharge is defined as spontaneous or bloody nipple
discharge from a single duct unilaterally during a nonlacta-
tional period.5 The most common causes of pathological
nipple discharge are benign lesions, such as intraductal
papillomas and mammary duct ectasia,6 however, an
underlying malignant lesion can be found in 10e15% of
patients with pathological nipple discharge.7e9 Therefore,
further investigations are generally recommended.10 The
approach for assessing a patient with nipple discharge
should begin with a complete clinical history and a physical
examination.11 However, most patients with pathological
nipple discharge have normal imaging results. Additional
imaging that may be considered includes ductography and
contrast-enhanced MRI,12 but these cannot replace a histo-
logical examination of patients with pathological nipple
discharge.13 Surgical examination, including major duct
excision, microdochectomy and duct-lobular segmentec-
tomy, is thought to be the gold standard for the diagnosis
and treatment of patients with pathological nipple
discharge.Figure 2 Along with the demarcation line, the mammary
duct segment was dissected.
Figure 3 The fluorescence-enhanced mammary duct
segment with collecting duct was removed en bloc toward the
peripheral mammary parenchyma, along with the fluorescence
guide.
Figure 5 The pathological diagnosis was intraductal papil-
loma of the breast.
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imaging of a dilated mammary duct was successfully per-
formed, using the same fluorescence imaging technique
used for the sentinel lymph node biopsy for breast cancer
and intraoperative cholangiography during cholecystec-
tomy.3 We could fluorescently visualize the dilated
mammary duct segment by directly injecting the ICG solu-
tion into the dilated duct. A well-demarcated fluorescent
image was obtained of the mammary parenchyma, and
dissection along the video guide was easily performed, and
we were able to remove the target lesion successfully.
Under conventional methods, such as injecting dye solution
or inserting a guide into the dilated duct, we would not
have been able to see the dissection line on the mammary
tissue. Thus, we regard the fluorescence image of the ductFigure 4 The cystic lesion and dilated mammary duct were
fully removed, and could be seen in the resected specimen.segmentectomy obtained using ICG as a novel and useful
approach for the diagnosis and treatment of pathological
nipple discharge.
With regard to the technical aspects, injection of the
same concentration of ICG solution as is used during
sentinel node biopsy yielded too much fluorescent signal, so
we were unable to obtain an optimal image for duct seg-
mentectomy under such conditions. Compared with the
concentration used for the node biopsy, the diluted ICG
solution described provided optimal visualization of the
mammary duct and its segment.
This procedure was attempted in only three patients,
including two with intraductal papillomas and one with
a malignant lesion; all of which had a cystic lesion that
caused nipple discharge. All of the lesions were included in
the resected specimens, which had fluorescent signals.
Further investigation is needed to confirm whether the
fluorescent area is consistent with the ductal lesion,
includes it, or does not include the entire lesion in the case
of ductal carcinoma in situ or an extended ductal spreading
component.
In conclusion, we were able to apply fluorescence
imaging successfully for duct-lobular segmentectomy for
treatment of pathological nipple discharge. Under fluores-
cence observation of the ICG-injected mammary duct and
parenchyma, the lesion was successfully removed, along
with the well-demarcated line of the mammary
parenchyma.
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